Palvella Therapeutics (PVLA) Stock Research

Palvella Therapeutics

· PVLA

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

2.003 B

-3.77%

Monday

Palvella receives third year of grant funding from FDA for QTORIN

PVLA

Sep 28, 7:49 AM

Over a week ago

Palvella Therapeutics transferred with Buy rating at Chardan

PVLA

Sep 21, 6:18 AM

Palvella Therapeutics completes rolling submission of Qtorin NDA to FDA

PVLA

Aug 31, 7:34 AM

Palvella Therapeutics price target lowered by $3 at Truist

PVLA

Aug 5, 8:52 AM

Palvella Therapeutics price target raised by $5 at Canaccord, here's why

PVLA

Aug 5, 7:14 AM

Palvella Therapeutics reports Q2 EPS ($1.52), consensus ($1.15)

PVLA

Aug 4, 8:35 AM

Short Report: Bears book profits in Celcuity

Jul 26, 10:47 AM

H.C. Wainwright says Palvella selloff 'an overreaction' to FDA's BTD denial

PVLA

Jul 21, 1:10 PM

Palvella Therapeutics selloff a buying opportunity, says BTIG

PVLA

Jul 21, 6:33 AM

Palvella Therapeutics falls -13.6%

PVLA

Jul 20, 12:00 PM

Palvella Therapeutics falls -9.0%

PVLA

Jul 20, 10:00 AM

Ligand price target raised by $15 at Craig-Hallum, here's why

Jul 20, 8:40 AM

Palvella Therapeutics appoints Savara CEO Matt Pauls to board

Jun 30, 7:42 AM

Palvella submits first rolling new drug application to FDA for Qtorin

PVLA

Jun 29, 7:50 AM

FDA grants rolling review to Palvella Therapeutics Qtorin rapamycin

PVLA

Jun 22, 7:53 AM

Palvella Therapeutics completes Qtorin pre-new drug application meeting with FDA

PVLA

Jun 3, 7:39 AM

Palvella Therapeutics issued patent by USPTO for Qtorin pitavastatin program

PVLA

May 27, 7:46 AM

Palvella Therapeutics announces new data from SELVA, TOIVA studies

PVLA

May 20, 4:37 PM

Palvella Therapeutics announces new data from TOIVA trial of Qtorin

PVLA

May 15, 7:40 AM

Palvella Therapeutics initiated with bullish view at Stephens, here's why

PVLA

May 12, 5:18 AM

Palvella Therapeutics reports Q1 EPS ($1.20) vs. (74c) last year

PVLA

May 7, 9:14 AM

Palvella Therapeutics doses first patients in LOTU trial

PVLA

May 4, 7:49 AM

Palvella Therapeutics price target raised by $30 at Chardan, here's why

PVLA

Mar 31, 4:35 PM

Palvella Therapeutics price target raised by $10 at Oppenheimer, here's why

PVLA

Mar 31, 2:47 PM

Palvella Therapeutics rallies after 2025 report, corporate update

PVLA

Mar 31, 10:40 AM

Charts